Molecular switching system using glycosylphosphatidylinositol to select cells highly expressing recombinant proteins.
Ontology highlight
ABSTRACT: Although many pharmaceutical proteins are produced in mammalian cells, there remains a challenge to select cell lines that express recombinant proteins with high productivity. Since most biopharmaceutical proteins are secreted by cells into the medium, it is difficult to select cell lines that produce large amounts of the target protein. To address this issue, a new protein expression system using the glycosylphosphatidylinositol (GPI)-anchor was developed. PGAP2 is involved in processing GPI-anchored proteins (GPI-APs) during transport. In PGAP2 mutant cells, most GPI-APs are secreted into the medium. Here, we established a HEK293 cell line where endogenous PGAP2 was knocked out and exogenous PGAP2 was inserted with a piggyBac transposon in the genome. Using these cells, human lysosomal a
SUBMITTER: Matabaro E
PROVIDER: S-EPMC5481379 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA